Crossmark

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study

Crossref DOI link: https://doi.org/10.1136/openhrt-2015-000260

Published Online: 2015-11-03

Published Print: 2015-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Hage, Camilla

Lund, Lars H

Donal, Erwan

Daubert, Jean-Claude

Linde, Cecilia

Mellbin, Linda
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct00774709 at ClinicalTrials.gov

Documents that mention this clinical trial

The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study
https://doi.org/10.1007/s00380-016-0933-8

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study
https://doi.org/10.1136/openhrt-2015-000260